Real-world treatment patterns and clinical outcomes amongst patients with relapsed/refractory multiple myeloma previously treated with lenalidomide and an anti-CD38 monoclonal antibody
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
Key words
refractory multiple myeloma,lenalidomide,monoclonal antibody,clinical outcomes,real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined